Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Globe Investor

Inside the Market

Up-to-the-minute insights
on developing market news

Entry archive:

Growing flowers of cannabis intended for the medical marijuana market are shown in Moncton, N.B., on April 14, 2016. (Ron Ward/THE CANADIAN PRESS)
Growing flowers of cannabis intended for the medical marijuana market are shown in Moncton, N.B., on April 14, 2016. (Ron Ward/THE CANADIAN PRESS)

Monday's small-cap stocks to watch Add to ...

Subscribers Only

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

 Canopy Growth Corp. (CGC-T) is buying MedCann GmbH Pharma and Nutraceuticals (MedCann), a German-based pharmaceutical distributor.

"Germany has begun a process of enabling medical access to cannabis and through a policy that recognized Canopy as the first legal supply source from North America," stated CEO Bruce Linton in a release.

Report Typo/Error

Follow on Twitter: @BrendaBouw

 

More Related to this Story

Next story

loading